GM-CSF secreting leukemia vaccine
PreclinicalVaccine
GM-CSF secreting leukemia vaccine is one of 14 biologic programs targeting Stem Cell Transplantation. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
13
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
14 competitors in Stem Cell Transplantation
#DrugCompanyPhaseTrials
1Cytoxan
BBaxter Healthcare Corporation
Phase 3
Neupogen
EEastern Cooperative Oncology Group
Phase 3
Fludara
SanofiPhase 2
Atgam
NovartisPhase 2
Medrol
PfizerPhase 2
Mesnex
BBaxter Healthcare Corporation
Phase 2
Benadryl
PParkedale
Phase 2
Tylenol
KKenvue Brands
Phase 2
Cytoxan
UUS Oncology Research
Phase 2
Peripheral Blood Stem Cell
FFred Hutchinson Cancer Center
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Stem Cell Transplantation1 trial
GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies
Completed·—·N/A·NCT00426205·28 enrolled
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Vaccine[2]
- Highest Phase
- Preclinical[1]
- Company
- DDana-Farber Cancer Institute